ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,410Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 2343

$1.56M Total Retail Price of All Prescriptions

Rank: 21 out of 2343

787 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 787 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 787 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

3% of this provider’s 23,299 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
CALCITRIOL 1,170 925 10 1 189
SIMVASTATIN 1,156 893 2 1
LEVOTHYROXINE SODIUM 1,133 851 3 2
OMEPRAZOLE 1,107 808 4 4
WARFARIN SODIUM 1,051 956 5 8
FUROSEMIDE 836 692 6 6
LISINOPRIL 749 603 7 3
HYDROCODONE-ACETAMINOPHEN 680 544 S3 8 13
ATENOLOL 662 523 9 12
GLYBURIDE 633 482 R 10 10 62
AMLODIPINE BESYLATE 616 509 11 5
METOPROLOL TARTRATE 568 468 12 7
METFORMIN HCL 400 246 13 9
ATORVASTATIN CALCIUM 363 319 14 10
POTASSIUM CHLORIDE 319 274 15 18
CEPHALEXIN 312 235 16 111
DONEPEZIL HCL 305 305 17 21
KLOR-CON M20 296 275 18 44
GABAPENTIN 277 179 19 16
ALENDRONATE SODIUM 266 215 20 28
ALLOPURINOL 266 231 20 31
TAMSULOSIN HCL 260 225 22 29
HYDROCHLOROTHIAZIDE 248 224 23 11
NIFEDIPINE ER 231 169 24 89
POLYETHYLENE GLYCOL 3350 230 158 25 54
HEPARIN SODIUM 228 176 26 198
LANTUS 227 145 27 51
CLOPIDOGREL 218 193 28 26
PRAVASTATIN SODIUM 217 179 29 15
ISOSORBIDE MONONITRATE ER 212 201 30 32
LANTUS SOLOSTAR 209 143 31 101
CIPROFLOXACIN HCL 209 167 31 72
CARVEDILOL 206 156 33 27
CITALOPRAM HBR 198 174 34 17
ZETIA 198 170 34 52
ZOLPIDEM TARTRATE 184 126 36 24
DIOVAN 179 156 37 23
ALBUTEROL SULFATE 177 160 38 126
PREDNISONE 175 129 39 37
TRIAMTERENE-HCTZ 173 116 40 57
SINGULAIR 171 150 41 100
PLAVIX 163 151 42 38
EXELON 157 156 43 129
NAMENDA 156 154 44 36
MIRTAZAPINE 154 136 45 41
METOLAZONE 152 124 46 173
PRANDIN 148 144 47 140
JANTOVEN 147 110 48 81
ENOXAPARIN SODIUM 147 123 48 203
TRAMADOL HCL 139 109 50 25
METHYLPREDNISOLONE 136 113 51 122
SYNTHROID 133 90 52 40
GEMFIBROZIL 128 85 53 133
LAMOTRIGINE 127 90 54 194
OLANZAPINE 123 113 55 121
SULFAMETHOXAZOLE-TRIMETHOPRIM 123 94 55 120
NAPROXEN 122 71 57 108
GLIPIZIDE 120 112 58 56
RISPERIDONE 120 111 58 61
DOXYCYCLINE HYCLATE 119 97 60 180
NEXIUM 116 109 61 33
CYMBALTA 116 104 61 74
LOSARTAN POTASSIUM 116 99 61 19
CRESTOR 113 80 64 30
QUETIAPINE FUMARATE 112 83 65 77
MONTELUKAST SODIUM 112 94 65 181
PANTOPRAZOLE SODIUM 112 84 65 22
ABILIFY 109 109 68 159
OXYCODONE HCL 107 42 S2 69 67
RANITIDINE HCL 105 82 70 43
SPIRONOLACTONE 105 99 70 65
NIFEDICAL XL 103 102 72 148
VERAPAMIL ER 102 86 73 95
BUMETANIDE 102 87 73 91
DILTIAZEM 24HR CD 102 85 73 83
NOVOLOG FLEXPEN 98 74 76 212
PAROXETINE HCL 98 62 76 66
FAMOTIDINE 96 64 78 60
DIGOXIN 94 92 79 35
FENTANYL 93 49 S2 80 69
CELEBREX 92 71 81 71
JANUVIA 91 88 82 50
OXYCODONE-ACETAMINOPHEN 90 80 S2 83 49
NYSTATIN-TRIAMCINOLONE 88 77 84 249
SERTRALINE HCL 87 76 85 20
METOCLOPRAMIDE HCL 85 64 86 168
CARBIDOPA-LEVODOPA 83 68 87 85
INSULIN SYRINGE 82 56 88 102
ACTOS 82 66 88 125
MECLIZINE HCL 81 80 90 103
PRIMIDONE 81 57 90 318
SPIRIVA 81 71 90 48
DICLOFENAC SODIUM 81 58 90 155
NOVOLOG 76 54 94 110
PEN NEEDLE 76 47 94 119
ADVAIR DISKUS 73 59 96 34
ENALAPRIL MALEATE 73 55 96 58
ACTONEL 71 64 98 182
NUEDEXTA 71 54 98 428
ONGLYZA 71 59 98 211
FINASTERIDE 70 63 101 80
METOPROLOL SUCCINATE 70 70 101 14
NITROFURANTOIN 68 65 103 330
FLUTICASONE PROPIONATE 68 37 103 46
PHENYTOIN SODIUM EXTENDED 67 15 105 152
HYDROCORTISONE 66 60 106 225
DIVALPROEX SODIUM 64 34 107 105
COMBIVENT 64 23 107 144
VENLAFAXINE HCL ER 63 28 109 87
PROPRANOLOL HCL 62 0 110 132
CLOTRIMAZOLE-BETAMETHASONE 62 42 110 127
LEVETIRACETAM 62 47 110 104
FLUOXETINE HCL 62 40 110 82
SEROQUEL 61 38 114 171
LEVEMIR FLEXPEN 60 28 115 218
RAMIPRIL 56 26 116 90
DILTIAZEM 24HR ER 56 55 116 76
PROVENTIL HFA 55 46 118 558
VENTOLIN HFA 55 32 118 79
IBUPROFEN 55 18 118 75
QUINAPRIL HCL 55 38 118 73
LANSOPRAZOLE 54 34 122 162
OXYBUTYNIN CHLORIDE ER 53 53 123 149
HUMALOG 53 42 123 131
BETHANECHOL CHLORIDE 53 47 123 349
NYSTATIN 53 43 123 172
DILANTIN 52 13 127 327
VYTORIN 51 42 128 185
BUSPIRONE HCL 51 39 128 146
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 28, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.